Individuals engaging in regular cannabis consumption often exhibit a distinct physiological profile upon waking, characterized by significantly elevated levels of cortisol, commonly referred to as the body’s primary stress hormone. This compelling finding, emanating from comprehensive research conducted at Oregon State University, suggests a profound perturbation in the natural daily rhythm of the human stress response system among frequent users. The study’s implications are particularly noteworthy as they point to a potential biological signature associated with sustained cannabis exposure, opening new avenues for understanding its long-term physiological effects.
Spearheaded by Dr. Anita Cservenka from the OSU College of Liberal Arts, this groundbreaking investigation delves into the intricate relationship between habitual cannabis engagement and the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis represents the body’s principal neuroendocrine network, meticulously orchestrated to manage physiological and behavioral reactions to stress. It is a complex communication system comprising three key endocrine glands: the hypothalamus in the brain, the pituitary gland also in the brain, and the adrenal glands situated atop the kidneys. This axis plays a crucial role in regulating mood, energy levels, digestion, the immune system, and the body’s response to stressful stimuli. Published in the esteemed journal Cannabis, the study contributes vital insights to a relatively nascent field exploring the long-term biological ramifications of frequent cannabis exposure on this critical regulatory system.
A significant proportion of individuals report utilizing cannabis as a coping mechanism for stress, often experiencing immediate, albeit temporary, relief from psychological pressures. This perceived benefit contributes to the widespread use of cannabis, particularly in times of heightened anxiety or emotional strain. However, the OSU research posits a crucial paradox: while acute cannabis use may mitigate feelings of anxiety, sustained and frequent consumption might inadvertently disrupt the very biological mechanisms designed to modulate and resolve the stress response, potentially fostering a detrimental feedback loop. This dynamic underscores the complex interplay between perceived short-term benefits and potential long-term physiological alterations, suggesting that what begins as a coping strategy could, over time, interfere with the body’s intrinsic ability to manage stress effectively.
Central to the HPA axis’s function is cortisol, a glucocorticoid hormone synthesized and released by the adrenal glands. These glands, situated atop the kidneys, are pivotal in the endocrine system, with cortisol acting as a vital chemical messenger influencing a multitude of bodily processes. Universally recognized as the "stress hormone," its secretion is a fundamental component of the body’s fight-or-flight response, preparing an organism to confront or evade perceived threats. In moments of danger or psychological pressure, the hypothalamus signals the pituitary, which in turn stimulates the adrenals to produce and release cortisol, mobilizing energy reserves and dampening non-essential bodily functions to prioritize survival. Beyond its acute stress-management role, cortisol performs indispensable functions in maintaining overall physiological homeostasis.
Its diverse responsibilities include modulating the immune system’s inflammatory responses, assisting in the maintenance of stable blood pressure, and crucially regulating glucose metabolism and energy mobilization. Cortisol helps ensure that adequate glucose is available for immediate energy, particularly for the brain, and helps regulate the balance of salt and water in the body. While transient increases in cortisol are adaptive and beneficial for navigating challenging circumstances, persistently elevated levels can precipitate a cascade of adverse health outcomes. Chronic hypercortisolemia is well-documented to correlate with heightened susceptibilities to various mental health conditions, including anxiety disorders and clinical depression, alongside an increased predisposition to cardiovascular diseases, such as hypertension and atherosclerosis. The body’s intricate balance, therefore, relies on the precise and rhythmic regulation of cortisol levels throughout the day, with typical patterns showing high levels in the morning that gradually decline towards evening.
The OSU team, including Dr. Cservenka and colleagues Julia Donner and Alexia Obrochta, specifically concentrated their analytical efforts on a phenomenon known as the Cortisol Awakening Response (CAR). CAR refers to the characteristic surge in cortisol production that naturally occurs in almost all individuals shortly after waking, typically reaching its zenith approximately 30 minutes post-arousal. This physiological event is considered a crucial biological marker, reflecting the body’s anticipatory preparation for the day’s forthcoming demands and potential stressors. A healthy CAR signifies the body’s readiness to engage with the environment and mobilize resources, indicating a well-regulated HPA axis. Deviations from this normal pattern can suggest underlying physiological dysregulation.
To quantify CAR, researchers meticulously collect salivary cortisol samples at two distinct time points: immediately upon waking and again precisely 30 minutes later. Saliva collection is a non-invasive method that accurately reflects circulating free cortisol levels. The subsequent calculation, involving the subtraction of the initial measurement from the second, yields a value that reflects the magnitude of this morning physiological readiness. Intriguingly, the OSU investigation revealed that while the increment in cortisol levels – the actual "rise" or magnitude of the CAR – was largely comparable between frequent cannabis users and non-users, a critical divergence emerged at the baseline. Individuals who reported consistent cannabis consumption initiated their day with a significantly higher circulating concentration of cortisol already present in their systems at the moment of awakening. This elevated starting point, rather than the subsequent increase, distinguished the user group, suggesting that their HPA axis might be chronically overactive or less efficient at returning to baseline levels overnight.
The implications of these findings are particularly pertinent given the substantial and accelerating increase in cannabis use across the United States, especially within younger adult demographics. Recent statistical analyses indicate that nearly three out of ten adults aged 19 to 30 reported cannabis consumption within the preceding month, a prevalence rate that has almost doubled over the last decade and a half. Furthermore, the proportion of individuals within this age bracket engaging in frequent use—defined as at least 20 times within a 30-day period—now surpasses 10%, a figure more than twice that observed 15 years prior. This upward trend, fueled by evolving societal perceptions, increased accessibility, and a growing number of states legalizing cannabis, underscores the urgency of understanding the physiological consequences associated with regular cannabis exposure. As cannabis becomes more mainstream, comprehensive research into its long-term health effects becomes increasingly vital for public health guidance.
Dr. Cservenka is careful to emphasize that the current cross-sectional study establishes a correlation rather than a direct causal link. The research does not definitively prove that frequent cannabis use causes elevated morning cortisol, nor does it demonstrate that higher cortisol levels directly lead to increased cannabis consumption. Establishing such a cause-and-effect relationship would necessitate rigorous longitudinal studies, meticulously tracking the same individuals over extended durations to observe changes in both cannabis use patterns and HPA axis function over time. Nevertheless, Cservenka highlights the potential for elevated cortisol levels upon awakening to serve as a valuable neurobiological indicator, or "marker," for identifying problematic patterns of cannabis use, a hypothesis that warrants considerable future exploration. Such a marker could be invaluable for early intervention strategies or for understanding the physiological underpinnings of cannabis use disorder.
This particular finding distinguishes itself from certain prior investigations where researchers observed a blunted or diminished CAR in regular cannabis users. This divergence underscores the inherent complexity and multifaceted nature of the interaction between cannabis and the body’s intricate stress response system. Dr. Cservenka attributes these discrepancies to various factors, including variations in analytical methodologies employed across studies, such as different methods for cortisol collection or different statistical approaches for analyzing the CAR, and distinct characteristics within the participant populations, such as age, gender, frequency and duration of cannabis use, and the types or potencies of cannabis consumed. Such nuances reinforce the idea that the relationship is not monolithic and requires careful consideration of experimental design and subject demographics to draw robust conclusions.
Despite these complexities, the OSU research strongly supports the plausible notion that individuals engaging in frequent cannabis use may experience tangible disruptions in their endogenous daily stress rhythms. This dysregulation could conceivably contribute to a self-perpetuating feedback loop: an impaired or dysregulated stress response system might, in turn, increase an individual’s susceptibility or propensity to seek out and utilize cannabis more frequently as a perceived coping mechanism. This cycle could exacerbate the very stress issues cannabis is often used to alleviate, creating a challenging physiological and psychological dependency. This potential cycle emphasizes the critical need for further research into the long-term physiological adaptations and potential maladaptations associated with consistent cannabis exposure. The study thus serves as an an invaluable foundational step, opening new avenues for understanding the broader physiological impacts of cannabis on human health and well-being, particularly concerning mental health and stress resilience.
The comprehensive research undertaking received financial support from Oregon State University, with additional contributions from the OSU Center for the Humanities and the OSU College of Liberal Arts, underscoring the institution’s commitment to advancing scientific understanding in this evolving area of public health.



